231:
204:
177:
150:
123:
489:
Introduced in 2002, Bard's
Recovery brand IVC filter was associated with 27 deaths and several hundred non-fatal problems. A "confidential study commissioned by Bard showed that the Recovery filter had higher rates of relative risk for death, filter fracture and movement than all of its competitors."
497:
released their investigation of the G2 series filters. According to the NBC report, the G2 filter was just a modified version of the
Recovery filter with "similar and potentially fatal flaws". Bard was reported to be aware of this shortly after the G2 was put on the market, but rather than recalling
453:
By 2010, Bard and other makers of vaginal mesh were being sued by women who alleged that the devices were responsible for their medical pain and injuries. Their legal cases cited poor design and unsafe materials, and claimed that some patients required "multiple surgeries to remove" the device. In
501:
In 2018, an
Arizona court ordered Bard to pay $ 1.6 million to a plaintiff for injuries sustained from a G2 IVC filter implanted in 2007, plus an additional $ 2 million in punitive damages. Bard challenged the verdict, but in October 2020, a court of appeals refused to overturn the ruling.
461:
Although Bard maintained that their vaginal mesh was "safe and effective", they began negotiations in 2013 to settle the nearly 30,000 legal claims. By August 2015, Bard had agreed to pay more than $ 200 million, thereby resolving about one-fifth of the outstanding lawsuits at that time.
429:
In 2006, a complaint was filed against C. R. Bard, alleging that the company paid illegal kickbacks to both physicians and consumers. In 2013, Bard agreed to pay $ 48.26 million to resolve the allegations relating to submitting false claims to
346:
discomfort. The company formally incorporated in 1923, and three years later, in 1926, Charles R. Bard sold the company to John F. Willits and Edson L. Outwin for $ 18,000. Under
Willits and Outwins, the company expanded into the
941:
880:
766:
961:
413:
in 1968. Over time, the company introduced a variety of new health care products, and its net sales first exceeded $ 1 billion in 1994. Around 2012, Bard acquired the company
Lutonix.
951:
653:
498:
the filters, kept them on the market for five years. According to Bard and FDA records, at least 12 deaths and hundreds of problems had been linked to the G2 series filters.
946:
936:
981:
701:
966:
730:
852:
971:
523:
416:
On April 23, 2017, it was announced that C. R. Bard would be bought by BD for $ 24 billion. On
December 29, 2017, the acquisition was completed.
976:
761:
537:
826:
582:
956:
354:
In 1948, C. R. Bard's annual sales topped $ 1 million for the first time, and the company moved its headquarters from New York City to
142:
663:
617:
38:
561:
658:
586:
455:
691:
790:
74:
677:
633:
716:
471:
304:
431:
446:
is a device that is surgically implanted into the vagina to strengthen pelvic muscles or organs, or to treat
410:
406:
323:
276:
913:
311:
company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the
931:
376:
for the first time ever. Bard continued to innovate in the world of catheters, rolling out the bipolar
744:
The live link is to the first of three pages. All content available in a single page via
Archive Link.
458:
required that Bard and other manufacturers study the rates of organ damage linked to the mesh devices.
342:
by
Charles R. Bard in 1907. Bard's first business involved importing Gomenol, which was used to treat
609:
447:
280:
234:
207:
180:
153:
126:
692:"Becton Dickinson buys CR Bard for $ 24 billion to form medical supply giant; Bard shares surge 20%"
721:
479:
355:
490:
Bard never recalled the
Recovery filter, but instead developed G2 series filters to replace it.
390:
in 1960. In 1961, Bard expanded beyond catheters, and began manufacturing products related to
613:
443:
486:
blood clots in the legs from moving into the heart or lungs (a condition that can be fatal).
639:
387:
377:
319:
264:
223:
359:
351:
business, introducing the Foley catheter in 1934 and the
America Woven Catheter in 1940.
601:
800:
791:"C.R. Bard negotiating to settle thousands of lawsuits involving vaginal-mesh implants"
475:
399:
312:
259:
925:
857:
339:
565:
391:
366:
308:
169:
48:
299:
specialty fields. C. R. Bard marketed its products and services worldwide to
483:
395:
373:
369:. Three years later the company began selling Foley catheters that came in
300:
284:
322:. The transaction was completed later that year, and the company became a
17:
494:
380:
363:
348:
296:
292:
101:
881:"9th Circuit upholds bellwether plaintiff's win in Bard IVC filter MDL"
583:"BD Completes Bard Acquisition, Creating New Global Health Care Leader"
549:
370:
343:
288:
654:"Intact Vascular raises $ 15.5M, developing stapler to replace stents"
628:, derived from eucalyptus tree, which relieved his urinary discomfort.
37:
795:
853:"Ninth Circuit Stands by Ruling OKing $ 3.6 Million Bard Judgment"
384:
196:
524:
C.R. Bard (BCR) annual SEC income statement filing via Wikinvest.
318:
In April 2017, C. R. Bard announced that it would be acquired by
696:
538:
C.R. Bard (BCR) annual SEC balance sheet filing via Wikinvest.
307:, extended care facilities, and alternate site facilities. An
762:"Bard Said to Pay $ 200 Million to Settle Vaginal-Mesh Cases"
780:
Archived copy provides free access to full article content.
624:
During a trip to Europe, he encountered a medicine called
942:
Companies formerly listed on the New York Stock Exchange
827:"Why Did Firm Keep Selling Problem Blood-Clot Filters?"
519:
517:
515:
279:, USA, was a developer, manufacturer, and marketer of
717:"Top Whistleblower Settlements of 2013—To Date"
113:
Vascular, Urology, Oncology, and Surgical Specialties
606:
Entrepreneur Magazine Encyclopedia of Entrepreneurs
258:
248:
221:
194:
167:
140:
117:
109:
91:
81:
70:
62:
54:
44:
825:Sandler, Tim; Gosk, Stephanie (31 December 2015).
760:
533:
531:
962:Medical technology companies of the United States
474:(or "blood clot filter") is a device that is
8:
754:
752:
750:
589:. December 29, 2017 – via PR Newswire.
577:
575:
30:
952:Companies based in Union County, New Jersey
820:
818:
602:"Charles R. Bard [C.R. Bard, Inc.]"
36:
29:
947:Health care companies based in New Jersey
937:Health care companies established in 1907
910:Historical business data for C. R. Bard:
600:Hallet, Anthony; Hallett, Diane (1997).
511:
982:American companies established in 1907
733:from the original on November 13, 2013
879:Grzincic, Barbara (August 13, 2020).
7:
967:1907 establishments in New York City
851:Steinberg, Julie (October 1, 2020).
704:from the original on April 24, 2017.
769:from the original on August 8, 2015
715:Tycko, Jonathan (August 31, 2013).
652:George, John (September 5, 2012),
456:Food and Drug Administration (FDA)
358:. In 1954, a Bard scientist, Dr.
320:Becton, Dickinson and Company (BD)
25:
662:, bizjournals.com, archived from
362:(1908-2008), developed the first
466:Inferior vena cava (IVC) filters
338:C. R. Bard, Inc. was founded in
230:
229:
203:
202:
176:
175:
149:
148:
122:
121:
972:1960s initial public offerings
409:in 1963 and was listed on the
1:
977:2017 mergers and acquisitions
759:Feely, Jef (August 4, 2015).
659:Philadelphia Business Journal
587:Becton, Dickinson and Company
265:Becton, Dickinson and Company
564:. Bard. 2017. Archived from
700:. Reuters. April 23, 2017.
425:Illegal kickback settlement
998:
957:New Providence, New Jersey
75:New Providence, New Jersey
550:CR Bard at Yahoo! Finance
472:inferior vena cava filter
305:health care professionals
35:
562:"BD Acquisition of Bard"
482:. It is used to prevent
411:New York Stock Exchange
324:wholly-owned subsidiary
277:Murray Hill, New Jersey
493:On December 31, 2015,
383:in 1958 and the first
27:Pharmaceutical company
678:registration required
634:registration required
610:John Wiley & Sons
803:. September 30, 2013
438:Vaginal mesh devices
326:of BD, rebranded as
281:medical technologies
66:Charles Russell Bard
722:National Law Review
275:, headquartered in
250:Number of employees
32:
666:on August 26, 2014
612:. pp. 27–28.
356:Summit, New Jersey
585:(Press release).
478:implanted in the
444:transvaginal mesh
285:vascular medicine
270:
269:
244:
217:
190:
163:
136:
105:
16:(Redirected from
989:
895:
894:
892:
891:
876:
870:
869:
867:
865:
848:
842:
841:
839:
837:
822:
813:
812:
810:
808:
787:
781:
778:
776:
774:
764:
756:
745:
742:
740:
738:
712:
706:
705:
688:
682:
681:
674:
673:
671:
649:
643:
640:Internet Archive
637:
630:
597:
591:
590:
579:
570:
569:
568:on June 6, 2017.
558:
552:
546:
540:
535:
526:
521:
388:balloon catheter
378:temporary pacing
360:Michael DeBakey
273:C. R. Bard, Inc.
238:
233:
232:
226:
211:
206:
205:
199:
184:
179:
178:
157:
152:
151:
143:Operating income
130:
125:
124:
99:
40:
33:
21:
997:
996:
992:
991:
990:
988:
987:
986:
922:
921:
918:
904:
899:
898:
889:
887:
878:
877:
873:
863:
861:
850:
849:
845:
835:
833:
824:
823:
816:
806:
804:
789:
788:
784:
779:
772:
770:
758:
757:
748:
743:
736:
734:
714:
713:
709:
690:
689:
685:
675:
669:
667:
651:
650:
646:
638:(Full text via
631:
620:
599:
598:
594:
581:
580:
573:
560:
559:
555:
547:
543:
536:
529:
522:
513:
508:
468:
454:2012, the U.S.
440:
427:
422:
336:
251:
222:
195:
172:
145:
98:
97:Timothy M. Ring
94:
84:
28:
23:
22:
15:
12:
11:
5:
995:
993:
985:
984:
979:
974:
969:
964:
959:
954:
949:
944:
939:
934:
924:
923:
920:
919:
917:
916:
911:
907:
903:
902:External links
900:
897:
896:
871:
843:
814:
801:Bloomberg News
782:
746:
707:
683:
644:
618:
592:
571:
553:
541:
527:
510:
509:
507:
504:
476:percutaneously
467:
464:
439:
436:
426:
423:
421:
418:
400:anesthesiology
335:
332:
313:Foley catheter
268:
267:
262:
256:
255:
252:
249:
246:
245:
227:
219:
218:
200:
192:
191:
173:
168:
165:
164:
146:
141:
138:
137:
119:
115:
114:
111:
107:
106:
95:
92:
89:
88:
85:
82:
79:
78:
72:
68:
67:
64:
60:
59:
56:
52:
51:
46:
42:
41:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
994:
983:
980:
978:
975:
973:
970:
968:
965:
963:
960:
958:
955:
953:
950:
948:
945:
943:
940:
938:
935:
933:
930:
929:
927:
915:
912:
909:
908:
906:
905:
901:
886:
882:
875:
872:
860:
859:
858:Bloomberg Law
854:
847:
844:
832:
828:
821:
819:
815:
802:
798:
797:
792:
786:
783:
768:
765:. Bloomberg.
763:
755:
753:
751:
747:
732:
728:
724:
723:
718:
711:
708:
703:
699:
698:
693:
687:
684:
679:
665:
661:
660:
655:
648:
645:
641:
635:
629:
627:
621:
619:0-471-17536-6
615:
611:
607:
603:
596:
593:
588:
584:
578:
576:
572:
567:
563:
557:
554:
551:
545:
542:
539:
534:
532:
528:
525:
520:
518:
516:
512:
505:
503:
499:
496:
491:
487:
485:
481:
477:
473:
465:
463:
459:
457:
451:
449:
445:
437:
435:
433:
424:
419:
417:
414:
412:
408:
403:
401:
397:
393:
389:
386:
382:
379:
375:
372:
368:
365:
361:
357:
352:
350:
345:
341:
340:New York City
333:
331:
329:
325:
321:
316:
314:
310:
306:
303:, individual
302:
298:
294:
290:
286:
282:
278:
274:
266:
263:
261:
257:
254:14,000 (2015)
253:
247:
242:
236:
228:
225:
220:
215:
209:
201:
198:
193:
188:
182:
174:
171:
166:
161:
155:
147:
144:
139:
134:
128:
120:
116:
112:
108:
104:) & (CEO)
103:
96:
90:
86:
80:
76:
73:
69:
65:
61:
57:
53:
50:
47:
43:
39:
34:
19:
932:BD (company)
888:. Retrieved
884:
883:. In Brief.
874:
862:. Retrieved
856:
846:
834:. Retrieved
830:
805:. Retrieved
794:
785:
771:. Retrieved
735:. Retrieved
726:
720:
710:
695:
686:
670:September 5,
668:, retrieved
664:the original
657:
647:
625:
623:
605:
595:
566:the original
556:
544:
500:
492:
488:
469:
460:
452:
448:incontinence
441:
428:
420:Legal issues
415:
404:
353:
337:
327:
317:
272:
271:
240:
224:Total equity
213:
197:Total assets
186:
159:
132:
71:Headquarters
45:Company type
914:SEC filings
864:January 16,
737:November 6,
407:went public
405:C. R. Bard
309:S&P 500
83:Area served
926:Categories
890:2023-01-16
773:January 1,
506:References
392:cardiology
367:prosthesis
170:Net income
93:Key people
49:Subsidiary
18:C. R. Bard
836:1 January
807:April 15,
484:deep-vein
396:radiology
374:packaging
315:in 1934.
301:hospitals
87:Worldwide
831:NBC News
767:Archived
731:Archived
702:Archived
495:NBC News
432:Medicare
381:catheter
364:arterial
349:catheter
297:surgical
293:oncology
110:Products
102:Chairman
885:Reuters
729:(243).
626:Gomenol
371:sterile
344:urinary
334:History
289:urology
283:in the
241:FY 2010
214:FY 2010
187:FY 2010
160:FY 2010
133:FY 2010
118:Revenue
63:Founder
55:Founded
796:NJ.com
616:
398:, and
295:, and
260:Parent
237:1.63B
210:3.17B
129:2.72B
77:, U.S.
385:latex
183:509M
156:730M
866:2023
838:2016
809:2014
775:2016
739:2013
697:CNBC
672:2012
614:ISBN
442:The
328:Bard
235:US$
208:US$
181:US$
154:US$
127:US$
58:1907
31:Bard
727:III
480:IVC
470:An
434:.
928::
855:.
829:.
817:^
799:.
793:.
749:^
725:.
719:.
694:.
656:,
642:.)
622:.
608:.
604:.
574:^
530:^
514:^
450:.
402:.
394:,
330:.
291:,
287:,
893:.
868:.
840:.
811:.
777:.
741:.
680:)
676:(
636:)
632:(
548:"
243:)
239:(
216:)
212:(
189:)
185:(
162:)
158:(
135:)
131:(
100:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
